Zytogenetische Charakterisierung der Glioblastomzelllinie G112 in Bezug auf tumorstammzellähnliche Eigenschaften und Strahlentherapie
Cytogenetic Characterisation Of Glioblastoma Cell Line G112 Concerning Tumor Stem Cell Like Properties And Radiotherapy
by Marina Rippl
Date of Examination:2013-01-07
Date of issue:2013-01-09
Advisor:PD Dr. Bastian Gunawan
Advisor:PD Dr. Ella Kim
Referee:PD Dr. Bastian Gunawan
Referee:Prof. Dr. Detlef Haase
Referee:Prof. Dr. Patricia Virsik-Köpp
Files in this item
Name:rippl.pdf
Size:1.61Mb
Format:PDF
Abstract
English
The glioblastoma multiforme (GBM) is the most frequent and the most malignant brain tumor showing the highest rate of anaplasia (WHO Grade IV) (Riede and Schaefer 2001b). The prognosis is bad (Mueller 2006) despite multi-modal and evergrowing new methods of treatment (Omay and Vogelbaum 2009; Mueller 2006; Weller 2008; Fukushima et al. 2009; Tabatabai and Stupp 2010). Many hypotheses about the origin of GBM are being discussed (Reya et al. 2001). The “GBM-Stem-Cell-Model
Keywords: Glioblastoma multiforme; Cell-line G112; Brain Tumor Initiating Cells; Radiotherapy; Cell culture; Cytogenetical Differences
Schlagwörter: Glioblastoma multiforme; Zelllinie G112; Tumorstammzellhypothese; Strahlentherapie; Zellkultur; Chromosomenanalyse